Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vosoritide in Children With Idiopathic Short Stature
NCT06382155Phase 2Recruiting
- Sponsor
- BioMarin Pharmaceutical
- Start
- Oct 2024
- Primary completion
- Jun 2026
- Modality
- Peptides
- Countries
- 6
01
Overview
A Phase 2 trial of vosoritide in Idiopathic Short Stature (ISS), sponsored by BioMarin Pharmaceutical. Started Oct 2024; status: recruiting.
02
Drugs
vosoritide
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT06382155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06382155.